Drug development

#Drug delivery #Drug development #Formulation

Streamlining development with containment in early drug discovery

Gurmeet Singh, Senior Director at West Pharmaceutical Services & Jeff Kyle, Senior Director of Wearable Delivery Systems explore how a focus on containment in early drug discovery can help ease the development process later on. It may seem counterintuitive to spend time and money on planning for containment… Read More

#Exclusive Content

#Drug development #Regulatory

Addressing the developability gap in pharma

Listen to this article on the DDW Podcast: Susan A Darling, Senior Director, CE and Biopharma, SCIEX and Todd Stawicki, Senior Global Marketing Manager, Biopharma, SCIEX examine advanced analytical technologies can help ensure that biopharma candidates are commercialisable. Developability in the biopharmaceutical industry relates to the difficulty… Read More

#Exclusive Content

Clinical trial
#Clinical trials #Drug development #Podcast

Latest DDW Podcast: Transforming clinical trials

This is the latest episode of the free DDW podcast, “Now is the time for the transformation of clinical trials”. It covers two narrated articles written for Volume 22, Issue 4 – Fall 2021 of DDW. They are called “Clinical trials, the pandemic and technology” and “Pharma and the… Read More

#News

Clinical trial
#Clinical trials #Drug development #Narrated podcasts

Now is the time for the transformation of clinical trials

This is the latest episode of the free narrated DDW podcast, “Now is the time for the transformation of clinical trials”. It covers two narrated articles written for Volume 22, Issue 4 – Fall 2021 of DDW. They are called “Clinical trials, the pandemic and technology” and… Read More

#Podcasts

#Drug development #Manufacturing

Altasciences continues manufacturing expansion in the US 

Contract research organisation (CRO) Altasciences is expanding its formulation, manufacturing and analytical services in the US as part of a project with the biopharmaceutical company Alladapt Immunotherapeutics.  Altasciences is building dedicated facilities for Alladapt to help with the company’s Phase III and commercial requirements.  … Read More

#News

Monoclonal antibody
#Biologics #Biopharma #Drug development

New ebook: The researcher’s guide to Dynamic Light Scattering

This e-book by NanoTemper looks at the workflows researchers are using in the biologics space and the benefits dynamic light scattering (DLS) offers. You will find out: What biologics are and why they’re important How DLS gives you information about your samples and what that data means Tips and… Read More

#News

#Drug development #Oncology #Podcast

Mini–library approach delivers an arsenal in drug development pipeline

This is the latest episode of the free DDW podcast, “Mini-library approach delivers an arsenal in drug development pipeline”. It covers a narrated article written for Volume 22, Issue 3 –Summer 2021 of DDW. In the article, Dr. Naganna Nimishetti, Chief of the Small Molecule Drug Discovery Division (SMDD) and… Read More

#News

#Drug development #Narrated podcasts #Oncology #Podcast

Mini-library approach delivers an arsenal in drug development pipeline

This is the latest episode of the free narrated DDW podcast, “Mini-library approach delivers an arsenal in drug development pipeline”. It covers a narrated article written for Volume 22, Issue 3 –Summer 2021 of DDW. In the article, Dr. Naganna Nimishetti, Chief of the Small Molecule Drug Discovery… Read More

#Podcasts

#AI #Drug development #Drug discovery

Iktos teams up with Sygnature Discovery on development project  

Artificial intelligence company Iktos has announced a collaboration with drug discovery company Sygnature Discovery in a deal designed to accelerate drug discovery and development.  The three-year deal will see Sygnature using Iktos’ de novogenerative design software Makya to facilitate rapid and efficient design of novel… Read More

#News

#Automation / robotics #Biologics #Biopharma #Drug development

Driving production in biologics development with automation

Drug development technology has evolved rapidly in recent years, and with the industry, advancement comes an increased capability of producing high-quality targeted large molecule drugs such as biologics and biosimilars. Since most biologics are large molecules, they may prove challenging to develop and manufacture on the large scale. Read More

#News

#AI / data analytics / healthtech / informatics #Drug development #Events #Medtech #Public health

Back in-person for 2022: LSX World Congress returns

For the last seven years, the LSX World Congress has bought together biotech, medtech and healthtech executives to connect with the capital, intelligence, innovation, and partners they need to grow their businesses. Back in-person for 2022, the 8th Congress takes place 10-11 May at 133 Houndsditch in London. … Read More

#News #Trending News

#Clinical research #Drug development #Drug discovery #Supply chain

Achieving faster drug lifecycle management 

Eugene Polini, Technical Key Account Manager at Datwyler examines the challenges drug developers are facing to speed up production lifecycles and what solutions are available to them.  While people around the world hope to never see another global pandemic in their lifetimes, it is the responsibility of pharmaceutical manufacturers to… Read More

#News

#Drug development #Finance #Investment

Boyds records growth following investment strategy  

Global drug development consultancy Boyds has reported strong financial growth following a two-year strategy to expand its business.  Boyds saw an increase of over 20% year-on-year in annual revenue in the wake of increased demand for drug development expertise across the UK, US, and Europe. … Read More

#News

#Assays #Biopharmaceuticals #Biotherapeutics #Drug development #Drug discovery

PerkinElmer releases assay kits for more effective biotherapeutics 

PerkinElmer has announced two ready-to-use HTRF and AlphaLISA no-wash assay kits designed to quickly and easily detect and quantify CHO HCP impurities during biopharmaceutical manufacturing.   Recombinant therapeutic proteins, such as monoclonal antibodies, some vaccines and other biologics, must be free of residual host cell protein (HCP) impurities… Read More

#News

#Clinical trial #Drug development #Drug discovery #Therapeutics

Rani Therapeutics initiates Phase I study osteoporosis drug 

Rani Therapeutics, a clinical stage biotherapeutics company focused on the oral delivery of biologics, has initiated a Phase I study of RT-102, an oral formulation of the human parathyroid hormone analog PTH(1-34) for the treatment of osteoporosis, delivered via capsule.  The first subject has been administered RT-102… Read More

#News